Abstract
Breast Cancer is a disease that results from the alteration of the cellular genome in breast tissue and can lead to the second cause of cancer death in human so that it is an object of intensive research. APOBEC3H is a member of APOBEC3 sub-family of DNA cytosine deaminases, which have evolved as a crucial role of innate immune defense and have been contributing to cancer development throughout genetic mutations. Eighty subjects were conducted to this study, forty subjects for each breast cancer patients and healthy group. Blood samples were analyzed for this study. After clotting blood sera were used to determine the quantity of APOBEC3H protein by Elisa technique. This study demonstrates that APOBEC3H expression on the level of protein is significantly down-regulated in breast cancer patients compared to that of a healthy group. This study reveals that the APOBEC3H expression on the level of protein can be used as a potential biomarker for predicting breast cancer with the significant high value of AUC.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Indian Journal of Public Health Research & Development
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
